INBX
Inhibrx Inc

610
Mkt Cap
$1.12B
Volume
229,070.00
52W High
$94.57
52W Low
$10.81
PE Ratio
-7.54
INBX Fundamentals
Price
$74.13
Prev Close
$77.23
Open
$77.23
50D MA
$78.50
Beta
0.87
Avg. Volume
209,628.85
EPS (Annual)
$116.58
P/B
30.40
Rev/Employee
$1,242.24
$78.38
Loading...
Loading...
News
all
press releases
Readystate Asset Management LP Acquires 143,324 Shares of Inhibrx Biosciences, Inc. $INBX
Readystate Asset Management LP lifted its stake in Inhibrx Biosciences, Inc. (NASDAQ:INBX - Free Report) by 534.1% in the third quarter, according to the company in its most recent filing with the...
MarketBeat·10d ago
News Placeholder
More News
News Placeholder
Inhibrx Biosciences, Inc. $INBX Shares Sold by Credit Industriel ET Commercial
Credit Industriel ET Commercial reduced its position in Inhibrx Biosciences, Inc. (NASDAQ:INBX - Free Report) by 54.9% in the 3rd quarter, according to the company in its most recent 13F filing with...
MarketBeat·12d ago
News Placeholder
Inhibrx Biosciences (NASDAQ:INBX) Shares Down 6.8% - Here's What Happened
Inhibrx Biosciences (NASDAQ:INBX) Shares Down 6.8% - Here's What Happened...
MarketBeat·15d ago
News Placeholder
Short Interest in Inhibrx Biosciences, Inc. (NASDAQ:INBX) Rises By 63.1%
Inhibrx Biosciences, Inc. (NASDAQ:INBX - Get Free Report) saw a significant increase in short interest during the month of December. As of December 31st, there was short interest totaling 1,712,725...
MarketBeat·1mo ago
News Placeholder
Inhibrx Biosciences, Inc. (NASDAQ:INBX) Sees Large Decline in Short Interest
Inhibrx Biosciences, Inc. (NASDAQ:INBX - Get Free Report) was the recipient of a large decrease in short interest in December. As of December 15th, there was short interest totaling 1,049,942 shares...
MarketBeat·2mo ago
News Placeholder
Inhibrx Biosciences (NASDAQ:INBX) Stock Price Up 7.2% - Should You Buy?
Inhibrx Biosciences (NASDAQ:INBX) Trading 7.2% Higher - What's Next...
MarketBeat·2mo ago
News Placeholder
Why Inhibrx's Recent Strength May Not Be Built to Last
An analysis of Inhibrx's sharp rally after trial results, highlighting a timing mismatch in the cycle and risks investors should watch.read more...
Benzinga·2mo ago
News Placeholder
Inhibrx Biosciences (NASDAQ:INBX) Shares Down 7.9% - Here's Why
Inhibrx Biosciences (NASDAQ:INBX) Stock Price Down 7.9% - Here's What Happened...
MarketBeat·2mo ago
News Placeholder
Inhibrx Biosciences (NASDAQ:INBX) Reaches New 1-Year High - Here's Why
Inhibrx Biosciences (NASDAQ:INBX) Reaches New 52-Week High - Should You Buy...
MarketBeat·2mo ago
News Placeholder
Inhibrx Biosciences Provides Progress Updates on the INBRX-106 Program and the Expansion Cohorts of the ozekibart (INBRX-109) Program
Inhibrx Biosciences Provides Progress Updates on the INBRX-106 Program and the Expansion Cohorts of the ozekibart (INBRX-109) Program Inhibrx Biosciences Provides Progress Updates on the INBRX-106...
PR Newswire·2mo ago
<
1
2
...
>

Latest INBX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.